Episode 33 - Ray Jordan and Pharmaceutical Industry's Reputation and Image

My guest in this episode is Ray Jordan. Ray is Principal at Putnam Insights. Ray Jordan is a corporate affairs leader and reputational growth driver in healthcare, technology, biotechnology and consumer industries and has worked with or for companies such as Moderna, Amgen, Johnson & Johnson and Pfizer. Ray has been recognized numerous times by industry sources such as PRWeek, and PRovoke Media. He has helped companies get recognized for high reputational status, including in such rankings by FORTUNE, Axios/Harris, Science Magazine, Dow Jones and others. In this candid interview about the pharmaceutical industry's image and reputation, Ray and I talk about: - What an image crisis looks like from a leader's point of view. - The current pharma reputation landscape and the Gallup poll. - Pharma industry wide efforts to address this. - Difference between big and small pharma reputation needs and - The relationship between reputation and market cap. If you're interested in how corporations, particularly pharma companies, manage their public image, reputation, and any public issues, this episode is for you. Here's Ray Jordan.

You can listen to Episode 33 - Ray Jordan and Pharmaceutical Industry's Reputation and Image online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 33 - Ray Jordan and Pharmaceutical Industry's Reputation and Image is an episode from The Future of Pharma by Samir Gondalia, ISPE Boston.

This episode is 48:05 long.

This episode was published on Apr 30, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Future of Pharma when more episodes are available from the podcast feed.